| Monoallelic MUTYH carrier status is not associated with increased breast cancer risk in a multigene panel cohort |
|
|
|
|
|
|
|
|
|
| A squamous cell carcinoma in a young woman with Lynch syndrome |
|
|
|
|
|
|
|
|
|
| Hereditary brain tumor with a homozygous germline mutation in PMS2: pedigree analysis and prenatal screening in a family with constitutional mismatch repair deficiency (CMMRD) syndrome |
|
|
|
|
|
|
|
|
|
| Germline mutation p.N363K in POLE is associated with an increased risk of colorectal cancer and giant cell glioblastoma |
|
|
|
|
|
|
|
|
|
| Cleft lip/palate and hereditary diffuse gastric cancer: report of a family harboring a CDH1 c.687 + 1G > A germline mutation and review of the literature |
|
|
|
|
|
|
|
|
|
| Boosting care and knowledge about hereditary cancer: European Reference Network on Genetic Tumour Risk Syndromes |
|
|
|
|
|
|
|
|
|
| Risk of multiple colorectal cancer development depends on age and subgroup in individuals with hereditary predisposition |
|
|
|
|
|
|
|
|
|
| Ovarian small cell carcinoma in one of a pair of monozygous twins |
|
|
|
|
|
|
|
|
|
| Referral frequency, attrition rate, and outcomes of germline testing in patients with pancreatic adenocarcinoma |
|
|
|
|
|
|
|
|
|
| Development and pilot testing of a leaflet informing women with breast cancer about genomic testing for polygenic risk |
|
|
|
|
|
|
|
|
|
| Electronically ascertained extended pedigrees in breast cancer genetic counseling |
|
|
|
|
|
|
|
|
|
| Genetic counselling of young women with breast cancer for Li–Fraumeni syndrome: a nationwide survey on the experiences and attitudes of genetics professionals |
|
|
|
|
|
|
|
|
|
| Interest in, willingness-to-pay for and willingness-to-recommend genetic testing for prostate cancer among affected men after radical prostatectomy |
|
|
|
|
|
|
|
|
|
| Massive juvenile polyposis of the stomach in a family with SMAD4 gene mutation |
|
|
|
|
|
|
|
|
|
| The BRCA1 exon 13 duplication: clinical characteristics of 22 families in Northern Sweden |
|
|
|
|
|
|
|
|
|
| Candidate susceptibility variants in angioimmunoblastic T-cell lymphoma |
|
|
|
|
|
|
|
|
|
| Modified capture–recapture estimates of the number of families with Lynch syndrome in Central Ohio |
|
|
|
|
|
|
|
|
|
| Outcome of thyroid ultrasound screening in FAP patients with a normal baseline exam |
|
|
|
|
|
|
|
|
|
| Molecular analysis of an asbestos-exposed Belgian family with a high prevalence of mesothelioma |
|
|
|
|
|
|
|
|
|
| Capillary electrophoresis as alternative method to detect tumor genetic mutations: the model built on the founder BRCA1 c.4964_4982del19 variant |
|
|
|
|
|
|
|
|
|
| Low-level parental mosaicism in an apparent de novo case of Peutz–Jeghers syndrome |
|
|
|
|
|
|
|
|
|
| Cholesterol profile in women with premature menopause after risk reducing salpingo-oophorectomy |
|
|
|
|
|
|
|
|
|
| The uptake of presymptomatic genetic testing in hereditary breast-ovarian cancer and Lynch syndrome: a systematic review of the literature and implications for clinical practice |
|
|
|
|
|
|
|
|
|
| The development of an online decision aid to support persons having a genetic predisposition to cancer and their partners during reproductive decision-making: a usability and pilot study |
|
|
|
|
|
|
|
|
|
| Identification of a novel GREM1 duplication in a patient with multiple colon polyps |
|
|
|
|
|
|
|
|
|
| Delineating a new feature of constitutional mismatch repair deficiency (CMMRD) syndrome: breast cancer |
|
|
|
|
|
|
|
|
|
| Sarcoma in neurofibromatosis 2: case report and review of the literature |
|
|
|
|
|
|
|
|
|
| Report of a bi-allelic truncating germline mutation in TP53 |
|
|
|
|
|
|
|
|
|
| Physician interpretation of variants of uncertain significance |
|
|
|
|
|
|
|
|
|
| Reminders of cancer risk and pain catastrophizing: relationships with cancer worry and perceived risk in women with a first-degree relative with breast cancer |
|
|
|
|
|
|
|
|
|
| Prevalence of thyroid diseases in familial adenomatous polyposis: a systematic review and meta-analysis |
|
|
|
|
|
|
|
|
|
| Unsolicited information letters to increase awareness of Lynch syndrome and familial colorectal cancer: reactions and attitudes |
|
|
|
|
|
|
|
|
|
| Hemangioblastoma in Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome: a phenotypic overlap between VHL and HLRCC Syndromes |
|
|
|
|
|
|
|
|
|
| Germline CDH1 mutations are a significant contributor to the high frequency of early-onset diffuse gastric cancer cases in New Zealand Māori |
|
|
|
|
|
|
✓ |
|
New Zealand Māori |
| Clinical and pathologic characteristics of breast cancer patients carrying the c.3481_3491del11 mutation |
|
|
|
|
|
|
|
|
|
| Urological sequelae of desmoids associated with familial adenomatous polyposis |
|
|
|
|
|
|
|
|
|
| Discussions about predictive genetic testing for Lynch syndrome: the role of health professionals and families in decisions to decline |
|
|
|
|
|
|
|
|
|
| Response to letter to editor regarding published article—metachronous colorectal cancer following segmental or extended colectomy in Lynch syndrome: a systematic review and meta-analysis |
|
|
|
|
|
|
|
|
|
| Clinical interpretation of pathogenic ATM and CHEK2 variants on multigene panel tests: navigating moderate risk |
|
|
|
|
|
|
|
|
|
| A retrospective review of 48 individuals, including 12 families, molecularly diagnosed with hereditary leiomyomatosis and renal cell cancer (HLRCC) |
|
|
|
|
|
|
|
|
|
| The first two confirmed sub-Saharan African families with germline TP53 mutations causing Li-Fraumeni syndrome |
|
|
|
|
|
|
✓ |
|
sub-Saharan African |
| Commentary: PREMM5 threshold of 2.5% is recommended to improve identification of PMS2 carriers |
|
|
|
|
|
|
|
|
|
| Mutations in SUFU and PTCH1 genes may cause different cutaneous cancer predisposition syndromes: similar, but not the same |
|
|
|
|
|
|
|
|
|
| Risk management adherence following genetic testing for hereditary cancer syndromes: a Singaporean experience |
|
|
|
|
|
|
|
|
|
| APC mosaicism in a young woman with desmoid type fibromatosis and familial adenomatous polyposis |
|
|
|
|
|
|
|
|
|
| Letter to the editor |
|
|
|
|
|
|
|
|
|
| Gene expression analysis in peripheral blood cells of patients with hereditary leiomyomatosis and renal cell cancer syndrome (HLRCC): identification of NRF2 pathway activation |
|
|
|
|
|
|
|
|
|